A new therapy to eradicate Helicobacter pylori was effective in half of asymptomatic children tested, according to two reports in the Journal of Pediatric Gastroenterology & Nutrition.
Researchers found that 44.3 percent and 52.9 percent of children receiving this quadruple sequential therapy had their infection eradicated compared with 12.2 percent and 15.4 percent with iron or placebo only.
One group of researchers found no difference in cure rates between the group receiving iron supplements and the placebo group. Another group of researchers studying the same children found that children whose H. pylori had been successfully eradicated had an average increase in serum ferritin three times that of those who remained infected.
Read the report in the Journal of Pediatric Gastroenterology & Nutrition on Helicobacter pylori.
Read more coverage of Helicobacter Pylori:
- Empire BCBS Launches Educational Initiative on AGA, ACG's Recommendation for H. pylori Testing
- ASGE Issues Guidelines Addressing Ethnicity, GI Diseases and Endoscopy
Researchers found that 44.3 percent and 52.9 percent of children receiving this quadruple sequential therapy had their infection eradicated compared with 12.2 percent and 15.4 percent with iron or placebo only.
One group of researchers found no difference in cure rates between the group receiving iron supplements and the placebo group. Another group of researchers studying the same children found that children whose H. pylori had been successfully eradicated had an average increase in serum ferritin three times that of those who remained infected.
Read the report in the Journal of Pediatric Gastroenterology & Nutrition on Helicobacter pylori.
Read more coverage of Helicobacter Pylori:
- Empire BCBS Launches Educational Initiative on AGA, ACG's Recommendation for H. pylori Testing
- ASGE Issues Guidelines Addressing Ethnicity, GI Diseases and Endoscopy